IFNA1 and systemic lupus erythematosus: A likely explanation is that B cell–derived autoantibodies and/or autoantibody-containing immune complexes trigger IFN expression in tissue-resident immune cells, which consequently provokes the IFN response observed in PBMCs of patients with SLE.